Guardant Health
GH
#1819
Rank
โ‚น1.018 T
Marketcap
โ‚น7,766
Share price
-4.56%
Change (1 day)
106.30%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -โ‚น277.33

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น296.70. In 2024 the company made an earnings per share (EPS) of -โ‚น329.05 an increase over its 2023 EPS that were of -โ‚น395.60.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น277.33-15.72%
2024-โ‚น329.05-16.82%
2023-โ‚น395.60-33.13%
2022-โ‚น591.5560%
2021-โ‚น369.7255.04%
2020-โ‚น238.47207.14%
2019-โ‚น77.64-19.81%
2018-โ‚น96.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-โ‚น256.08-13.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น197.80-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA